Skip to main content

Home/ health information/ Group items tagged #dermatology

Rss Feed Group items tagged

kunalkumar03

Doing Dermarollers the right way! - YouTube - 1 views

  •  
    If you have dry & aging skin then choose Dermaroller. At Dr. Nivedita Dadu's Dermatology Clinic we provide this treatment with the addition of rejuvenating serums like hyaluronic acid. This helps counter fine lines and provide hydration & suppleness to the facial skin. The derma roller can be used for treating both men and women. It has various benefits to the skin such as: 1. Cellulite Removal Treatment 2. Anti-Aging Treatment 3. Using Minoxidil 5% along with Dermaroller for effective Hair Fall Treatment 4. Skin Smoothing Treatment 5. Scar Removal Treatment 6. Stretch Mark Treatment
kunalkumar03

Pigmentation Treatment | Patient Testimonial | Dr. Nivedita Dadu- Best Dermatologist in... - 1 views

  •  
    https://youtu.be/_OBH5XZ8ZL8 #darkspots #pigmentation #skintreatments #lasertreatmentindelhi #skinglow #skintreatment #new #howto #best #india #delhi #dermatology #dermatologist #skinspecialist #skincare #skintreatment #skinsolution
pharmacybiz

Adtralza UK Approval : Dermatological Solution by LEO Pharma - 0 views

  •  
    The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution developed by Danish specialist LEO Pharma. This injectable solution contains 300 mg of tralokinumab in a 2 mL pre-filled pen and will be available for tralokinumab patients in the UK from early 2024. Tralokinumab is indicated for treating moderate-to-severe atopic dermatitis in adult and adolescent patients aged 12 and older who require systemic therapy, Leo Pharma said in a statement. It is a fully human monoclonal antibody developed to specifically bind to and inhibit the IL-13 cytokine. Previously, it was available in a 150 mg in 1 mL pre-filled syringe. According to Leo Pharma, the 300 mg tralokinumab in a 2 mL pre-filled pen offers a streamlined administration for both patients and prescribers. It begins with an initial 600 mg dose in two injections, followed by a single 300 mg maintenance dose administered every other week. "We're pleased that this simplified administration method for tralokinumab will soon benefit eligible atopic dermatitis patients in the UK. It aligns with our commitment to elevate the standard of care and support for individuals with skin conditions," said Leanne Walsh, Vice President and General Manager of UK and Ireland at LEO Pharma.
mdnewsline

Transform Skin Care with MD Newsline! - 1 views

  •  
    Stay at the forefront of dermatology innovation with MD Newsline, your trusted partner for advanced insights in skin health. Discover What's Inside: * Cutting-Edge Dermatology Research to stay informed. * Innovative Treatment Insights that elevate patient care. * Culturally Sensitive Resources to meet diverse needs. Why MD Newsline? Empowering healthcare professionals with reliable, expert-led content that transforms patient outcomes and advances the field of dermatology. Access Exclusive Skin Care Insights Today! Join a vibrant community committed to redefining skin health. Visit https://mdnewsline.com/ Your journey to revolutionizing dermatology starts now-explore MD Newsline!
1 - 4 of 4
Showing 20 items per page